European Journal of Endocrinology · 2011 · 50 citations · 20 references
MedicineEndocrinologySurgeryEndocrine OncologyEndocrine SurgeryHemodynamic ManagementCardiovascular InstabilityEndocrine Tumor SurgeryHemodynamic DisordersPheochromocytoma SurgeryArterial Blood Pressure MeasurementBlood Pressure InstabilityHemodynamic Instability AssessmentMultiple Endocrine Neoplasia Type 2BSystolic Blood Pressure
OBJECTIVE: Hemodynamic (HD) instability still underlies difficulties during pheochromocytoma resection. Little is known about HD instability in patients with multiple endocrine neoplasia (MEN) type 2-related pheochromocytoma. Our aim was to assess differences in HD during pheochromocytoma resection between MEN2 and non-MEN patients. In addition, we sought to identify risk factors for intraoperative HD instability. DESIGN: Retrospective cohort study. METHODS: A total of 22 MEN2 and 34 non-MEN patients underwent 61 pheochromocytoma resections at the University Medical Center Utrecht between 2000 and 2010. All MEN2-related pheochromocytomas were diagnosed by annual screening. HD instability was assessed by measuring the frequency of hypotensive (mean arterial blood pressure (MABP) <60 mmHg) and/or hypertensive (systolic arterial blood pressure (SABP) >200 mmHg) episodes. RESULTS: Compared with non-MEN patients, MEN2 patients were younger at diagnosis, had less symptoms, lower hormone levels, and smaller tumors. Intraoperatively, MEN2 patients had a similar frequency of hypertensive episodes (1.3 vs 1.9, P=0.162, 95% confidence interval (CI): -6.7 to 35.4) and a similar maximum SABP (200 vs 220 mmHg, P=0.180, 95% CI: -9.7 to 50.5). However, MEN2 patients experienced less frequent (1.04 vs 2.6, P=0.003, 95% CI: 0.57 to 2.6) and less severe hypotensive episodes after tumor resection (lowest MABP: 52.5 vs 45.6 mmHg, P=0.015, 95% CI: -12.6 to 1.16). Tumor size was an independent risk factor for HD instability for the total group after multivariate analysis. CONCLUSION: MEN2 patients with pheochromocytoma, despite their smaller tumors, do not distinguish themselves from non-MEN patients in terms of hypertensive episodes during pheochromocytoma resection. Therefore, pretreatment with α- and β-blockade remains the standard of care in MEN2-related as well as in non-MEN-related pheochromocytomas.
20
Clinical Experience Over 48 Years With Pheochromocytoma
Richard E. Goldstein, James A. O’Neill, George Holcomb et al. · Annals of Surgery · 1999 · 464 citations
Medicine, Endocrinology, Pathology +17
Graeme Eisenhofer, McClellan M. Walther, Thanh‐Truc Huynh et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 303 citations
Medicine, Endocrinology, Oncology +17
Pheochromocytoma ; currentstatus and changing trends
Ja Van Heerden · Medical Entomology and Zoology · 1982 · 205 citations